Cite
HARVARD Citation
Higano, C. et al. (n.d.). 827PClinical outcome with radium-223 (Ra-223) in patients (pts) previously treated with abiraterone (Abi) or enzalutamide (Enza): A retrospective study of real-world (RW) data from pts with metastatic castration-resistant prostate cancer (mCRPC). Annals of oncology. p. . [Online].